Health Canada
- Status: approved
🇨🇦 Wy21901 in Canada
Wy21901 (INDORAMIN) regulatory status in Canada.
Marketing authorisation
Wy21901 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Canada
Frequently asked questions
Is Wy21901 approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Wy21901 in Canada?
Marketing authorisation holder not available in our data.